Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa

Holden Comprehensive Cancer Center at University of Iowa is a clinical research site located in Iowa City, Iowa, United States 52242-1002.

Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Holden Comprehensive Cancer Center at University of Iowa has participated in 152 clinical trials with 3 currently active.

Therapeutic areas: Lymphoma, Breast Cancer, Ovarian Cancer.

Sponsors: Children's Oncology Group, Alliance for Clinical Trials in Oncology, Gynecologic Oncology Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Iowa City

Browse all research sites in Iowa · View every site in Iowa City

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Holden Comprehensive Cancer Center at University of Iowa?

Holden Comprehensive Cancer Center at University of Iowa has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Holden Comprehensive Cancer Center at University of Iowa conducted?

Holden Comprehensive Cancer Center at University of Iowa has 152 clinical trials on record, with 3 currently active. Their work covers Lymphoma, Breast Cancer, Ovarian Cancer.

Is Holden Comprehensive Cancer Center at University of Iowa accredited by Crixeo Clinical Trials?

Holden Comprehensive Cancer Center at University of Iowa has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Holden Comprehensive Cancer Center at University of Iowa?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.